Home > Qtrly Results > ZYDUS LIFESCIENCES

ZYDUS LIFESCIENCES
Quarterly Results Analysis [Mar2024]

ZYDUS LIFESCIENCES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for ZYDUS LIFESCIENCES
Please provide your vote to see the results

ZYDUS LIFESCIENCES Quarterly Results

Consolidated Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Revenues ₹5,534 Cr ₹4,505 Cr ₹4,369 Cr ₹5,140 Cr ₹5,011 Cr ₹4,257 Cr ₹4,006 Cr ₹3,964 Cr
Expenses ₹3,909 Cr ₹3,423 Cr ₹3,305 Cr ₹3,634 Cr ₹3,755 Cr ₹3,406 Cr ₹3,319 Cr ₹3,240 Cr
Operating Income ₹1,625 Cr ₹1,082 Cr ₹1,064 Cr ₹1,505 Cr ₹1,256 Cr ₹851 Cr ₹686 Cr ₹725 Cr
Other Income ₹162 Cr ₹58 Cr ₹136 Cr ₹36 Cr ₹38 Cr ₹144 Cr ₹174 Cr ₹174 Cr
Interest ₹35 Cr ₹20 Cr ₹9 Cr ₹18 Cr ₹28 Cr ₹33 Cr ₹35 Cr ₹34 Cr
Depreciation ₹205 Cr ₹195 Cr ₹184 Cr ₹180 Cr ₹179 Cr ₹182 Cr ₹182 Cr ₹181 Cr
Profit Before Tax ₹1,547 Cr ₹926 Cr ₹1,007 Cr ₹1,329 Cr ₹486 Cr ₹780 Cr ₹643 Cr ₹681 Cr
Profit After Tax ₹1,226 Cr ₹712 Cr ₹781 Cr ₹1,113 Cr ₹349 Cr ₹585 Cr ₹506 Cr ₹563 Cr
EPS ₹11.75 ₹7.80 ₹7.91 ₹10.74 ₹2.93 ₹6.16 ₹5.16 ₹5.06
Industry Peers & Returns1W1M1Y
ZYDUS LIFESCIENCES 1.9% 9% 100.9%
SUN PHARMACEUTICAL INDUSTRIES -0% 5% 47.2%
CIPLA 0.3% -1.8% 47.2%
DR REDDYS LABORATORIES 3.2% 11.5% 30.2%
DIVIS LABORATORIES 0.5% -0.4% 24.7%
MANKIND PHARMA 2.1% -4.1% 24.2%
TORRENT PHARMACEUTICALS 0.5% 2.7% 52%
LUPIN 1.1% 14.1% 96.9%
AUROBINDO PHARMA 3.1% 9.5% 80.3%

ZYDUS LIFESCIENCES Quarterly Revenues

Revenues
Q-o-Q

22.83 %

Y-o-Y

10.44 %

Quarters Revenues % Change
Mar2024 ₹5,534 Cr
22.83
Dec2023 ₹4,505 Cr
3.12
Sep2023 ₹4,369 Cr
-15.00
Jun2023 ₹5,140 Cr
2.57
Mar2023 ₹5,011 Cr
17.70
Dec2022 ₹4,257 Cr
6.28
Sep2022 ₹4,006 Cr
1.04
Jun2022 ₹3,964 Cr -

ZYDUS LIFESCIENCES Quarterly Operating Profit

Operating Profit
Q-o-Q

50.23 %

Y-o-Y

29.44 %

Quarters Operating Profit % Change
Mar2024 ₹1,625 Cr
50.23
Dec2023 ₹1,082 Cr
1.68
Sep2023 ₹1,064 Cr
-29.32
Jun2023 ₹1,505 Cr
19.89
Mar2023 ₹1,256 Cr
47.58
Dec2022 ₹851 Cr
24.01
Sep2022 ₹686 Cr
-5.31
Jun2022 ₹725 Cr -
Operating Margins
Q-o-Q

22.32 %

Y-o-Y

17.20 %

Quarters Operating Margin% % Change
Mar2024 29.37%
22.32
Dec2023 24.01%
-1.40
Sep2023 24.35%
-16.87
Jun2023 29.29%
16.88
Mar2023 25.06%
25.36
Dec2022 19.99%
16.70
Sep2022 17.13%
-6.29
Jun2022 18.28% -

ZYDUS LIFESCIENCES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

72.24 %

Y-o-Y

251.64 %

Quarters Profit After Tax % Change
Mar2024 ₹1,226 Cr
72.24
Dec2023 ₹712 Cr
-8.85
Sep2023 ₹781 Cr
-29.85
Jun2023 ₹1,113 Cr
219.31
Mar2023 ₹349 Cr
-40.40
Dec2022 ₹585 Cr
15.64
Sep2022 ₹506 Cr
-10.10
Jun2022 ₹563 Cr -
PAT Margins
Q-o-Q

40.19 %

Y-o-Y

218.25 %

Quarters PAT Margin(%) % Change
Mar2024 22.15 %
40.19
Dec2023 15.8 %
-11.58
Sep2023 17.87 %
-17.50
Jun2023 21.66 %
211.21
Mar2023 6.96 %
-49.34
Dec2022 13.74 %
8.79
Sep2022 12.63 %
-10.99
Jun2022 14.19 % -

ZYDUS LIFESCIENCES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

50.64 %

Y-o-Y

301.02 %

Quarters EPS % Change
Mar2024 ₹11.75
50.64
Dec2023 ₹7.8
-1.39
Sep2023 ₹7.91
-26.35
Jun2023 ₹10.74
266.55
Mar2023 ₹2.93
-52.44
Dec2022 ₹6.16
19.38
Sep2022 ₹5.16
1.98
Jun2022 ₹5.06 -

You may also like the below Video Courses